| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |